首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1624483

全球血氣監測系統市場規模（依產品類型、最終用戶、地區、範圍和預測）

Global Blood Gas Monitoring Systems Market Size By Product Type (Desktop Type, Portable Type), By End-User (Hospitals, Diagnostic Centers), By Geographic Scope And Forecast

出版日期: 2024年08月03日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

血氣監測系統的市場規模及預測

2024 年血氣監測系統市場規模價值 43.2 億美元，預計到 2031 年將達到 68.3 億美元，2024 年至 2031 年的複合年增長率為 5.88%。推動市場發展的關鍵因素是老年人口的增加和慢性病發病率的上升，從而促使住院人數的增加。全球血氣監測系統市場報告對市場進行了全面的評估。它對關鍵細分市場、趨勢、市場推動因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

血氣監測系統全球市場定義

血氣監測儀是一種測量血液中氧氣、二氧化碳和酸含量的設備。這些因素有助於診斷肺部疾病、休克和藥物過量等疾病。根據美國國家生物技術資訊中心（NCBI）的數據，血氣監測設備對於醫院重症監護病房（ICU）和心臟監護病房（CCU）至關重要。檢測患者的動脈血氣（ABG）對於確定和維持患者的氧合狀態和酸鹼平衡至關重要。

此診斷工具的有效性取決於對結果的正確解釋。酸鹼失衡會促使各種疾病的併發症，有時這些異常會變得嚴重到成為危及生命的危險因子。所有醫生，包括重症監護醫生和麻醉師，都應該徹底瞭解酸鹼平衡。 HCO3-（相對於 pCO2）、標準鹼過剩（SBE）和強離子差異（SID）是酸鹼生理學（SID）中最廣泛使用的三種方法。

Stewart 的 SID 概念已存在 20 多年，其定義為完全解離的陰離子和陽離子之間的絕對差異。動脈血氣監測是確定患者氧合、通氣和酸鹼狀態的首選方法。儘管非侵入性監測已在很大程度上取代了 ABG 監測，但 ABG 監測對於驗證和校準非侵入性監測方法仍然很有價值。脈搏血氧儀測量的血氧飽和度 (SpO2) 與實驗室血氧儀測量的 SaO2 不一樣。

脈搏血氧儀測量血紅素的功能飽和度。以還原血紅素和氧合血紅素總和的百分比來表示的氧合血紅素的量稱為功能飽和度。實驗室氧飽和度計使用不同的波長來區分不同形式的血紅蛋白（高鐵血紅蛋白和碳氧血紅蛋白），從而確定淨飽和分數，或含氧血紅蛋白佔總還原血紅蛋白的百分比。

血氣監測系統全球市場概況

對自動化臨床血氣分析儀的需求不斷增加是市場擴張的主要驅動力。這些分析儀能夠快速提供結果，易於使用、便於攜帶且週轉時間短，使其成為管理 ICU 和急診室氧合和通氣的必備工具。推動血液氣體監測系統市場成長的其他因素包括老年人口的增加和慢性病盛行率的上升、技術先進的生物感測器和數據分析軟體的採用率不斷提高以及技術整合綜合體數量的增加。的需求和POC血氣分析儀的小型化不斷增加。

此外，血氣分析儀與電子病歷和實驗室資訊系統的整合正在創造市場擴張的機會。這些整合技術不僅可以更好地監測患者，而且還有助於簡化工作流程。但由於即時診斷設備和血氣監測設備成本較高且部分國家監管要求嚴格，市場擴張受到限制。脈搏血氧儀可用於ICU的間歇監測或即時連續血氧飽和度測量。在全身麻醉和機械通氣期間，持續監測非常有益。對呼吸功能處於邊緣狀態的患者進行應激性操作（BAL、氣管灌洗、離心）時，可以使用脈搏血氧飽和度測定來檢測飽和度的變化。

幫助評估是否需要額外的氧氣補充。此外，由於血流是脈搏的，脈搏血氧儀感測器的輸出可以透過電子處理來提供脈搏波形和心率。因此，脈搏血氧儀可用於追蹤週邊脈搏的速率和規律。調節常量營養素（葡萄糖、蛋白質、脂肪）和微量營養素（維生素和微量元素）的供應，然後評估這些能量需求和供應之間的充分性，最後控制血糖，是 ICU 營養和代謝護理的關鍵組成部分。是我們的三個主要目標。

這是一個至關重要的問題，因為越來越多的證據表明，蛋白質和能量供應不足以及血糖控制不佳都與 ICU 中的不良臨床結果有關。 Alere（聖地牙哥）的企業護理點血液學系統是唯一使用智慧卡技術的無線床邊偵測選項。這項尖端技術將患者的檢查結果直接傳輸到 PDA（個人數位助理）和電子病歷，使醫生能夠留在患者的床邊。便攜式設備由於易於使用、操作和維護而具有較高的接受率。一些新興市場正在投資開發和銷售此類設備。

Blood Gas Monitoring Systems Market size was valued at USD 4.32 Billion in 2024 and is projected to reach USD 6.83 Billion by 2031, growing at a CAGR of 5.88% from 2024 to 2031 The primary factor driving the market is the growing elderly population and the rising frequency of chronic diseases, which leads to an increase in hospital admissions. The Global Blood Gas Monitoring Systems Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market

Global Blood Gas Monitoring Systems Market Definition

Blood gas monitors are instruments that measure the amount of oxygen, carbon dioxide, and acidity in the bloodstream. These factors contribute to the diagnosis of diseases such as lung disorders, shock, and drug overdoses, among others. According to the National Center for Biotechnology Information (NCBI), for intensive care units (ICU) and Cardiac Care Unit (CCU) rooms in the hospital, blood gas monitoring equipment is essential. The examination of a patient's arterial blood gas (ABG) is crucial for identifying and maintaining their oxygenation status and acid-base balance.

The effectiveness of this diagnostic tool is contingent on the ability to interpret the results appropriately. Acid-base imbalances can cause complications in a variety of diseases, and the aberration can sometimes be so severe that it becomes a life-threatening risk factor. Any physician, including an intensivist and an anesthesiologist, must have a good understanding of acid-base balance. The HCO3- (in the context of pCO2), standard base excess (SBE), and strong ion difference (SID) are the three most extensively utilized approaches to acid-base physiology (SID).

Stewart's idea of SID, which is defined as the absolute difference between totally dissociated anions and cations, has been around for more than 20 years. For determining a patient's oxygenation, ventilation, and acid-base status, arterial blood gas monitoring is the preferred method. Despite the fact that non-invasive monitoring has mostly supplanted ABG monitoring, it is still valuable for validating and calibrating non-invasive monitoring approaches. The oxygen saturation measured by a pulse oximeter (SpO2) and the SaO2 measured by a laboratory cooximeter is not the same.

The functional saturation of hemoglobin is measured by the pulse oximeter. The amount of oxygenated hemoglobin in a percentage form of total reduced and oxygenated hemoglobin is known as functional saturation. Cooximeters in laboratories uses various wavelengths to discriminate between different forms of hemoglobin (methemoglobin and carboxyhemoglobin) and so quantify genuine fractional saturation, or the amount of oxygenated hemoglobin in a percentage form of the total reduced.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Blood Gas Monitoring Systems Market Overview

The increased demand for automated and point-of-care blood gas analyzer devices is mostly responsible for the market's expansion. These analyzers provide quick results, are simple to use, portable, and have quick turnaround times, making them essential tools for managing oxygenation and ventilation in ICUs and emergency rooms. Other factors driving the growth of the Blood Gas Monitoring Systems Market include an older population and an increase in the prevalence of chronic diseases, increased adoption of technologically advanced biosensors and data analysis software, increasing demand for technology-integrated combined systems, and miniaturization of POC blood gas analyzers.

In addition, the integration of blood gas analyzers with electronic medical records and laboratory information systems is presenting a profitable opportunity for market expansion. These integrated technologies not only allow for excellent patient monitoring but also help to streamline the workflow. However, high prices for point-of-care devices and blood gas monitors, as well as severe regulatory requirements in some countries, limit market expansion. The pulse oximeter can be used in the ICU for intermittent monitoring or to offer a continuous real-time oxygen saturation reading. During general anesthesia or ventilation, continuous monitoring is very beneficial. When stressful treatments are performed on patients with borderline respiratory function (BALs, tracheal washes, centesis), the pulse oximeter can be utilized to detect changes in saturation.

It can help us assess whether or not more oxygen supplementation is required. Furthermore, because blood flow is pulsatile, the pulse oximeter sensor's output can be electronically processed to provide a pulse waveform and heart rate. As a result, the pulse oximeter can be used to track the rate and regularity of peripheral pulses. The regulation of macronutrients (glucose, protein, fat) and micronutrients (vitamins and trace elements) delivery, second, the assessment of the adequacy between energy needs and delivery, and finally, glycaemic control are the three primary goals of nutritional and metabolic care in the ICU.

This is a critical issue since a large body of evidence shows that inadequate protein and energy coverage, as well as poor glycemic management, are both linked to a poor clinical outcome in the ICU. The Alere (San Diego) Enterprise Point of Care blood analysis system is the only wireless bedside testing option that employs Smartcard technology. This cutting-edge technology sends patient results straight to a personal digital assistant (PDA) and the electronic medical record, allowing the doctor to remain at the patient's bedside. The portable devices are simple to use, handle, and maintain, which contributes to their higher acceptance rate. Several businesses are making investments in the development and marketing of these items. Though portable devices have an advantage over traditional devices.

Global Blood Gas Monitoring Systems Market Segmentation Analysis

The Global Blood Gas Monitoring Systems Market is Segmented on the basis of Product Type, End-User, And Geography.

Blood Gas Monitoring Systems Market, By Product Type

Desktop Type
Portable Type

Based on Product Type, The market is segmented into Desktop Type and Portable Type. There are numerous advantages to using an LED monitor. The biggest advantage is that they offer the highest image quality currently available. In general, a patient monitoring device consists of a sensor for gathering critical patient data (e.g., heart rate) and an interconnect solution (e.g., PCBs, connectors, wire, etc.) for transmitting the data to the capital equipment. The patient monitoring device component of a pulse oximeter, for example, is the piece that clips to your finger and senses and communicates your pulse to the capital equipment.

Blood Gas Monitoring Systems Market, By End-User

Hospitals
Cardiac Catheterization Laboratory
Diagnostic Centers
Ambulatory Surgical Centers
Others

Based on End-User, The market is segmented into Hospitals, Cardiac Catheterization Laboratory, Diagnostic Centers, Ambulatory Surgical Centers, Others. A hospital is a medical facility that treats patients with specialized health science and auxiliary healthcare personnel as well as medical equipment. Doctors use catheters instead of surgery to diagnose and treat heart diseases in the cardiac catheterization laboratory. A catheterization lab, rather than an operating room, can safely perform a variety of procedures. Catheters are plastic tubes that resemble spaghetti and are used to introduce special devices to diagnose or treat heart problems.

Blood Gas Monitoring Systems Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Geography, The Global Blood Gas Monitoring Systems Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. he Asia Pacific region is expected to witness a significant CAGR during the forecast period. This is primarily due to the primary factor driving the market is the growing elderly population and the rising frequency of chronic diseases, which leads to an increase in hospital admissions.

Key Players

The "Global Blood Gas Monitoring Systems Market" study report will provide a valuable insight with an emphasis on the global market including some of the major players such as
Abbott Laboratories, Alere, Inc, Instrumentation Laboratory, Mediacorp, Optimedical, Radiometer, Roche Diagnostics, SenTec AG, Siemens Healthcare, Sphere Medical.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

November 2020, In India, Abbott launched the FreeStyle Blood Glucose Monitor for diabetic adults and children (over the age of four) as well as women with gestational diabetes (diabetes during pregnancy).
November 2021, Abbott released late-breaking data from the global Leadless II IDE study, which looked at Abbott's investigational Aveir leadless pacemaker in people with specific irregular heart rhythms.
Jan 2019, Perimed AB and Radiometer Medical ApS have partnered to accelerate and increase the marketing of Perimed's PeriFlux 6000 CPO 2 standalone system.

1 INTRODUCTION OF GLOBAL BLOOD GAS MONITORING SYSTEMS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL BLOOD GAS MONITORING SYSTEMS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL BLOOD GAS MONITORING SYSTEMS MARKET, PRODUCT TYPE

5.1 Overview
5.2 Desktop Type
5.3 Portable Type

6 GLOBAL BLOOD GAS MONITORING SYSTEMS MARKET, BY END-USER

6.1 Overview
6.2 Hospitals
6.3 Cardiac Catheterization Laboratory
6.4 Diagnostic Centers
6.5 Ambulatory Surgical Centers
6.6 Others

7 GLOBAL BLOOD GAS MONITORING SYSTEMS MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East and Africa

8 GLOBAL BLOOD GAS MONITORING SYSTEMS MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Abbott Laboratories
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Alere, Inc.
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Instrumentation Laboratory
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 Medicacorp
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Optimedical
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 Radiometer
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 Roche Diagnostics
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 SenTec AG
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 Siemens Healthcare
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 Sphere Medical
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments